ACRX Past Earnings image   This ACRX past earnings page last updated 5/18/2022
ACRX Past Earnings
Data adjusted for ACRX split history

PeriodPast Earnings DateGAAP
Q1 20225/16/2022-0.060
Q4 20213/10/2022-0.060
Q3 202111/15/2021-0.070
Q2 20218/16/2021-0.080
Q1 20215/17/2021-0.080
Q4 20203/15/2021-0.100
Q3 202011/5/2020-0.100
Q2 20208/10/2020-0.080
Q1 20205/11/2020-0.200
Q4 20193/16/2020-0.180
Q3 201911/6/2019-0.160
Q2 20198/5/2019-0.160
Q1 20195/8/2019-0.170
Q4 20183/7/2019-0.18
Q3 201811/2/2018-0.21
Q2 20188/2/2018-0.2
Q1 20185/9/2018-0.23
Q4 20173/8/2018-0.2
Q3 201711/9/2017-0.28
Q2 20178/1/2017-0.29
Q1 20175/8/2017-0.34
Q4 20163/2/2017-0.21
Q3 201611/1/2016-0.25
Q2 20167/28/2016-0.24
Q1 20165/2/2016-0.25
Q4 20153/7/2016-0.24
Q3 201510/29/20150.11
Q2 20158/3/2015-0.2
Q1 20155/4/2015-0.27
Q4 20143/9/2015-0.32
Q3 201411/10/2014-0.13
Q2 20148/11/2014-0.3
Q1 20145/8/2014-0.22
Q4 20133/3/2014-0.18
Q3 201311/5/2013-0.26
Q2 20138/12/2013-0.22
Q1 20135/8/2013-0.34
Q4 20123/12/2013-0.41
Q3 201211/6/2012-0.38
ACRX Past Revenue
PeriodPast Earnings DateGAAP
Q1 20225/16/20220.00B
Q4 20213/10/20220.00M
Q3 202111/15/20210.00B
Q2 20218/16/20210.00B
Q1 20215/17/20210.00B
Q4 20203/15/20210.00B
Q3 202011/5/20200.00B
Q2 20208/10/20200.00B
Q1 20205/11/20200.00B
Q4 20193/16/20200.00B
Q3 201911/6/20190.00B
Q2 20198/5/20190.00B
Q1 20195/8/20190.00B
Q4 20183/7/2019613000
Q3 201811/2/2018377000
Q2 20188/2/2018818000
Q1 20185/9/2018343000
Q4 20173/8/2018740000
Q3 201711/9/20171.49M
Q2 20178/1/20172.66M
Q1 20175/8/20173.11M
Q4 20163/2/20176.43M
Q3 201611/1/20163.37M
Q2 20167/28/20164.53M
Q1 20165/2/20163.02M
Q4 20153/7/20161.73M
Q3 201510/29/201515.43M
Q2 20158/3/20151.92M
Q1 20155/4/2015181000
Q4 20143/9/2015226000
Q3 201411/10/20144.83M
Q2 20148/11/201471000
Q1 20145/8/2014100000
Q4 20133/3/201427.60M
Q3 201311/5/2013548000
Q2 20138/12/2013407000
Q1 20135/8/2013940000
Q4 20123/12/20131.70M
Q3 201211/6/2012166000
Quotes delayed 20 minutes

Email EnvelopeFree ACRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
AcelRx Pharmaceuticals (ACRX) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

ADGI Historical Earnings
ADIL Historical Earnings
ADMA Historical Earnings
ADMP Historical Earnings
ADMS Historical Earnings
ADPT Historical Earnings
ADTX Historical Earnings
ADUS Historical Earnings
ADVM Historical Earnings
ADXS Historical Earnings

ACRX Past Earnings Q&A

What was the best and worst ACRX past earnings results?
For AcelRx Pharmaceuticals, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest ACRX past earnings result in our data set was 0.11/share posted in Q3 2015, while the lowest was in Q4 2012 when ACRX posted -0.41/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q4 2013 when ACRX reported 27.60M in revenue, while the quarter with the lowest revenue in our data set was Q4 2021 at 0.00M of revenue.

  Suggested answer: There are 39 ACRX past earnings results in our data set.

On this page we presented the ACRX past earnings date information for AcelRx Pharmaceuticals. Reviewing that ACRX Past Earnings for the company, we see that the highest past earnings result in our data set was in Q3 2015, when ACRX posted gaap of 0.11/share. Meanwhile the lowest ACRX past earnings result was in Q4 2012, when ACRX posted gaap of -0.41/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q4 2013 when ACRX reported 27.60M in revenue, while the smallest revenue quarter was Q4 2021 when ACRX reported 0.00M in revenue.

Any self directed investor doing their due diligence on ACRX or any other given stock can benefit from researching all of the AcelRx Pharmaceuticals past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate AcelRx Pharmaceuticals past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for ACRX. Thanks for visiting, and the next time you need to research ACRX past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: Funds Holding EVK, Institutional Holders of TRWH, Top Ten Hedge Funds Holding SOHO.

 

ACRX Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.